https://doi.org/10.4081/reumatismo.2013.79
Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers
Submitted: 27 September 2012
Accepted: 9 May 2013
Published: 27 May 2013
Accepted: 9 May 2013
Abstract Views: 2986
PDF: 811
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Supporting Agencies
noneHow to Cite
Catarsi, E., Doveri, M., & Tavoni, A. (2013). Bosentan and sildenafil: successful treatment in a sclerodermic patient with refractory ulcers. Reumatismo, 65(2), 79–81. https://doi.org/10.4081/reumatismo.2013.79
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- A. Corrado, F.P. Cantatore, Dupuytren’s disease. State of the art and therapeutic perspectives , Reumatismo: Vol. 59 No. 2 (2007)
- S. Guiducci, M. Matucci Cerinic, Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis , Reumatismo: Vol. 61 No. 2 (2009)
- B. Frediani, M. Rossini, S. Adami, G. Bianchi, O. Di Munno, L. Sinigaglia, M. Antonelli, G. Minisola, Study of vitamin D status of rheumatoid arthritis patients Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR) , Reumatismo: Vol. 58 No. 4 (2006)
- R. Foti, R. Leonardi, G. Fichera, M. Di Gangi, C. Leonetti, P. Gangemi, R. De Pasquale, Buschke Scleredema, case report , Reumatismo: Vol. 58 No. 4 (2006)
- Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri, The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients , Reumatismo: Vol. 58 No. 1 (2006)
- D. Malesci, G. La Montagna, G. Valentini, The arthropathy of systemic sclerosis , Reumatismo: Vol. 57 No. 4 (2005)
- B. Marasini, M. Massarotti, R. Cossutta, L. Massironi, A. Mantero, Pulmonary hypertension in autoimmune rheumatic diseases , Reumatismo: Vol. 57 No. 2 (2005)
- P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo, The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases , Reumatismo: Vol. 57 No. 2 (2005)
- M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker, Sjögren’s syndrome and mean platelet volume , Reumatismo: Vol. 67 No. 1 (2015)
- S. Zeni, F. Ingegnoli, Raynaud’s phenomenon , Reumatismo: Vol. 56 No. 2 (2004)
You may also start an advanced similarity search for this article.
